European Journal of Clinical Pharmacology

, Volume 66, Issue 7, pp 727–733 | Cite as

Norwegian medical students’ attitudes towards the pharmaceutical industry

Pharmacoepidemiology and Prescription



Whereas there is a considerable body of information on the interaction between physicians and the pharmaceutical industry, little is known about the pharmaceutical industry–medical student relationship. We have assessed the extent of contact between Norwegian medical students and the pharmaceutical industry as well as the attitudes of these students towards the pharmaceutical industry.


A self-assessment questionnaire was distributed to fifth- and sixth-year students attending the four medical schools in Norway and to Norwegian medical students attending selected universities abroad.


A total of 65.8% of all eligible students returned a completed questionnaire. Of these, 73.9% had been exposed to various levels of contact with the pharmaceutical industry, but only 17.5% reported having a generally positive attitude towards the industry. The level of exposure did not correlate in students’ attitudes; rather, it correlated positively to a feeling of competence in terms of being able to handle such interactions. A majority of students responded that while they would decline accepting monetary gifts, they would welcome receiving reimbursements for meeting expenses, meals and educational material. Students favoured a practice of full disclosure of potential industry-related conflicts of interest among the university teaching staff. There were considerable differences in the students’ attitudes between universities, suggesting that medical students are prone to influence from university lecturers.


Norwegian medical students are opinionated, critical and curious with respect to pharmaceutical industry relations. This interest can be explored and probably also modified by educational initiatives.


Guidelines National survey Pharmaceutical promotion Questionnaire 



The authors want to thank The Norwegian University of Science and Technology for financing the project and Professor Stian Lydersen for valuable help with the statistics. The participation from staff and students at the different universities is gratefully acknowledged.


  1. 1.
    Lexchin J (1993) Interactions between physicians and the pharmaceutical industry: what does the literature say? Can Med Assoc J 149(10):1401–1407Google Scholar
  2. 2.
    Aasland OG, Forde R (2004) Physicians and drug industry: attitudes and practice. Tidsskr Nor Laegeforen 124(20):2603–2606PubMedGoogle Scholar
  3. 3.
    Prosser H, Walley T (2003) Understanding why GPs see pharmaceutical representatives: a qualitative interview study. Br J Gen Pract 53(489):305–311PubMedGoogle Scholar
  4. 4.
    Steinman MA, Shlipak MG, McPhee SJ (2001) Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 110(7):551–557CrossRefPubMedGoogle Scholar
  5. 5.
    Brodkey AC (2005) The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem. Acad Psychiatry 29(2):222–229. doi: 10.1176/appi.ap.29.2.222 CrossRefPubMedGoogle Scholar
  6. 6.
    Orlowski JP, Wateska L (1992) The effects of pharmaceutical firm enticements on physician prescribing patterns. There’s no such thing as a free lunch. Chest 102(1):270–273CrossRefPubMedGoogle Scholar
  7. 7.
    Wazana A (2000) Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 283(3):373–380CrossRefPubMedGoogle Scholar
  8. 8.
    Chren MM, Landefeld CS (1994) Physicians’ behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 271(9):684–689CrossRefPubMedGoogle Scholar
  9. 9.
    Bellin M, McCarthy S, Drevlow L, Pierach C (2004) Medical students’ exposure to pharmaceutical industry marketing: a survey at one U.S. medical school. Acad Med 79(11):1041–1045CrossRefPubMedGoogle Scholar
  10. 10.
    Hyman PL, Hochman ME, Shaw JG, Steinman MA (2007) Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry. Acad Med 82(1):94–99. doi: 10.1097/01.ACM.0000249907.88740.ef CrossRefPubMedGoogle Scholar
  11. 11.
    Sandberg WS, Carlos R, Sandberg EH, Roizen MF (1997) The effect of educational gifts from pharmaceutical firms on medical students’ recall of company names or products. Acad Med 72(10):916–918CrossRefPubMedGoogle Scholar
  12. 12.
    Sierles FS, Brodkey AC, Cleary LM, McCurdy FA, Mintz M, Frank J, Lynn DJ, Chao J, Morgenstern BZ, Shore W, Woodard JL (2005) Medical students’ exposure to and attitudes about drug company interactions: a national survey. JAMA 294(9):1034–1042. doi: 10.1001/jama.294.9.1034 CrossRefPubMedGoogle Scholar
  13. 13.
    Vainiomaki M, Helve O, Vuorenkoski L (2004) A national survey on the effect of pharmaceutical promotion on medical students. Med Teach 26(7):630–634. doi: 10.1080/01421590400004890 CrossRefPubMedGoogle Scholar
  14. 14.
    Vinson DC, McCandless B, Hosokawa MC (1993) Medical students’ attitudes toward pharmaceutical marketing: possibilities for change. Fam Med 25(1):31–33PubMedGoogle Scholar
  15. 15.
    Vuorenkoski L, Valta M, Helve O (2008) Effect of legislative changes in drug promotion on medical students: questionnaire survey. Med Educ 42(12):1172–1177. doi: 10.1111/j.1365-2923.2008.03169.x CrossRefPubMedGoogle Scholar
  16. 16.
    Wilkes MS, Hoffman JR (2001) An innovative approach to educating medical students about pharmaceutical promotion. Acad Med 76(12):1271–1277CrossRefPubMedGoogle Scholar
  17. 17.
    Wofford JL, Ohl CA (2005) Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. BMC Med Educ 5(1):5. doi: 10.1186/1472-6920-5-5 CrossRefPubMedGoogle Scholar
  18. 18.
    Members of Nmf and Medical Students in Total after University and Country by November 24, 2008 (In Norwegian) In: The Norwegian Medical Association. Available at:
  19. 19.
    (2005) Report from National Educational Meeting, October 20, 2005 (in Norwegian). The Norwegian University of Science and Technology, Trondheim. Available at:
  20. 20.
    (2005) Dean meeting in Trondheim, December 1–2, 2005 (in Norwegian). In: The Norwegian University of Science and Technology, Trondheim. Available at:
  21. 21.
    Agreement between the Pharmaceutical Industry Association and the Norwegian Medical Association regarding Guidelines for Cooperation and Interaction between Physicians, the Norwegian Medical Association and the Pharmaceutical Industry (in Norwegian). December 13, 2004 In: The Norwegian Medical Association. Available at:
  22. 22.
    Tichelaar J, Richir MC, Avis HJ, Scholten HJ, Antonini NF, De Vries TP (2009) Do medical students copy the drug treatment choices of their teachers or do they think for themselves? Eur J Clin Pharmacol. Epub ahead of print. doi: 10.1007/s00228-009-0743-3
  23. 23.
    Grande D, Frosch DL, Perkins AW, Kahn BE (2009) Effect of exposure to small pharmaceutical promotional items on treatment preferences. Arch Intern Med 169(9):887–893. doi:  10.1001/archinternmed.2009.64 CrossRefPubMedGoogle Scholar
  24. 24.
    Coombes R (2009) Stepping into the therapeutics void. Br Med J 338:a3179CrossRefGoogle Scholar
  25. 25.
    Watson PY, Khandelwal AK, Musial JL, Buckley JD (2005) Resident and faculty perceptions of conflict of interest in medical education. J Gen Intern Med 20(4):357–359. doi: 10.1111/j.1525-1497.2005.04075.x CrossRefPubMedGoogle Scholar
  26. 26.
    Hodges B (1995) Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. Can Med Assoc J 153(5):553–559Google Scholar
  27. 27.
    McGettigan P, Golden J, Fryer J, Chan R, Feely J (2001) Prescribers prefer people: the sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol 51(2):184–189CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Department of Laboratory Medicine, Children’s and Women’s HealthNorwegian University of Science and TechnologyTrondheimNorway
  2. 2.Department of Clinical PharmacologySt. Olav’s University HospitalTrondheimNorway
  3. 3.SandnesNorway

Personalised recommendations